Celldex Therapeutics (CLDX) Capital Expenditures (2010 - 2026)
Celldex Therapeutics' Capital Expenditures came in at $3.18 million for Q2 2026, up 336.7% from $728,000 a year earlier and up 94.0% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Capital Expenditures (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Celldex Therapeutics reported Capital Expenditures of $6.54 million, up 185.0% year-over-year; for FY2025, it was $2.71 million, up 41.4% from FY2024.
- Capital Expenditures carries a five-year compound annual growth rate of 11.8% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $1.92 million in FY2024 (+5.6%), $1.82 million in FY2023 (-0.5%), $1.83 million in FY2022 (+46.4%) and $1.25 million in FY2021 (-19.5%).
- The Q2 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q3 2010.
- Year-over-year, Capital Expenditures has increased for three consecutive quarters, with growth averaging 163.6% over the last eight quarters.
- The fastest year-over-year change in Capital Expenditures over five years came in Q1 2026 (growth of 518.5%), and the weakest in Q3 2023 (a decline of 54.5%).
- Business Quant data shows CLDX's Capital Expenditures at $1.64 million (Q1 2026), $1.28 million (Q4 2025) and $440,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Celldex Therapeutics | 2.31 Bn | 37.50 Mn | - | 3.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.18 Mn |
| Mar 31, 2026 | 1.64 Mn |
| Dec 31, 2025 | 1.28 Mn |
| Sep 30, 2025 | 440,000.00 |
| Jun 30, 2025 | 728,000.00 |
| Mar 31, 2025 | 265,000.00 |
| Dec 31, 2024 | 756,000.00 |
| Sep 30, 2024 | 545,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 344,000.00 |
| Dec 31, 2023 | 666,000.00 |
| Sep 30, 2023 | 157,000.00 |
| Jun 30, 2023 | 410,000.00 |
| Mar 31, 2023 | 585,000.00 |
| Dec 31, 2022 | 235,000.00 |
| Sep 30, 2022 | 345,000.00 |
| Jun 30, 2022 | 673,000.00 |
| Mar 31, 2022 | 575,000.00 |
| Dec 31, 2021 | 354,000.00 |
| Sep 30, 2021 | 185,000.00 |
API Access
Celldex Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();